CDC-RFA-CK22-2203: Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - NCEZID notices from 2021.
Centers for Disease Control - NCEZID offered grants to any type of organization. It expected to make about 12 awards worth $100 million in total. Applications closed on February 11, 2022.
From the official notice on Grants.gov, last changed December 3, 2021. Checked November 7, 2026.
- Total funding$100 million
- Expected awards12
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | December 3, 2021 |
|---|---|
| Deadline | February 11, 2022 |
| Archived by Grants.gov | March 13, 2022 |
Who can apply
This opportunity was open to any type of organization.
All 16 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Applicants can apply to one or both components. Within each component, an applicant may include a maximum of two strategies (as defined in the logic model). Applicants must clearly state the component(s) and strategy(ies) (as defined in the logic model) to which they are applying in the Project Abstract Summary. An application will be deemed non-responsive if an applicant includes more than two strategies (as defined in the logic model) for each component included in the application. The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Non-profit Institutions of Higher Education: Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native- and Native Hawaiian-serving institutions Hispanic-serving institutions
Is this a realistic fit?
- Most of the program's money (50% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The COVID-19 pandemic highlighted gaps in infection prevention and control (IPC) knowledge and practice in U.S. healthcare settings. IPC in healthcare stops the spread of infections, preventing illness and death and protecting patients and healthcare personnel. There is a need to strengthen healthcare IPC practices, inform IPC recommendations, improve how healthcare personnel IPC competencies are assessed, and develop evidence-based approaches to IPC training and education. This Notice of Funding Opportunity (NOFO) provides real-world implementation solutions for CDC’s evidence-based guidance, during both normal operations and during emergencies. Through this NOFO, CDC will continue to protect Americans by improving the safety and quality of healthcare. This NOFO supports the priorities of the National Center for Emerging and Zoonotic Infectious Diseases, including the prevention of the spread of infectious diseases by enhancing healthcare infection prevention and control (IPC). This NOFO will engage organizations (e.g., academic institutions, healthcare systems, and non-governmental organizations) not currently or routinely engaged by existing programs. CDC will establish and expand partnerships with academic, healthcare, and other organizations to address common IPC failure modes; enhance correct implementation of IPC protocols and work processes; and strengthen healthcare worker training and competency assessment. This NOFO supports activities to assess and remove barriers to success, improve communication of IPC information and instructions to healthcare workers, and understand how to optimize the layout and functional flow of healthcare environments and processes. This NOFO will support organizations uniquely positioned and have the capacity to advance the design, delivery, and effectiveness of IPC training, education, and competency assessment to improve healthcare worker IPC practice and increase health department support of healthcare IPC and outbreak response. The work conducted supports public health and healthcare practice by informing development of guidance and recommendations; translating guidance and recommendations into practices implementable in diverse healthcare settings; and improving how healthcare and public health personnel are trained and how competencies are assessed. The recipients supported through this two-component NOFO will lead efforts to improve implementation of healthcare IPC.
Who has won Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health grants before
From fiscal 2021 to 2025, Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health (93.421) awarded $2.7 billion across 312 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| National Foundation for the Centers for Disease Control & Prevention, Inc. | Georgia | 3 | $392 million |
| National Association of County and City Health Officials | District of Columbia | 2 | $162 million |
| The Association of State and Territorial Health Officials | Virginia | 4 | $124 million |
| Council of State and Territorial Epidemiologists, Inc. | Georgia | 2 | $120 million |
| National Association of Chronic Disease Directors, Inc. | Georgia | 2 | $105 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-CK22-2203 still open?
No. It closed on February 11, 2022.
Who can apply for Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States?
Centers for Disease Control - NCEZID accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States?
Closed February 11, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $100 million in total across about 12 awards.
Who has won Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health grants before?
The largest recipients over five fiscal years were National Foundation for the Centers for Disease Control & Prevention, Inc., National Association of County and City Health Officials, The Association of State and Territorial Health Officials. The program made 312 awards worth $2.7 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)